BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12228832)

  • 1. Mortality associated with breakthrough candidemia among patients with and those without cancer.
    Krcmery VC; Babela R
    Clin Infect Dis; 2002 Oct; 35(7):898; author reply 899. PubMed ID: 12228832
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.
    Uzun O; Ascioglu S; Anaissie EJ; Rex JH
    Clin Infect Dis; 2001 Jun; 32(12):1713-7. PubMed ID: 11360213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for breakthrough candidemia.
    Nucci M; Colombo AL
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):209-11. PubMed ID: 11957023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcome for breakthrough candidaemia in patients with cancer.
    Chung JW; Lee SO; Choi SH; Woo JH; Ryu J; Kim YS; Kim NJ
    Mycoses; 2006 Mar; 49(2):114-8. PubMed ID: 16466444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidemia in patients with ventricular assist devices.
    Shoham S; Shaffer R; Sweet L; Cooke R; Donegan N; Boyce S
    Clin Infect Dis; 2007 Jan; 44(2):e9-12. PubMed ID: 17173211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of candidemia in intensive care units.
    Bouza E; Muñoz P
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome.
    Kralovicova K; Spanik S; Oravcova E; Mrazova M; Morova E; Gulikova V; Kukuckova E; Koren P; Pichna P; Nogova J; Kunova A; Trupl J; Krcmery V
    Scand J Infect Dis; 1997; 29(3):301-4. PubMed ID: 9255894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in cancer patients with candidemia.
    Uzun O; Anaissie EJ
    Ann Oncol; 2000 Dec; 11(12):1517-21. PubMed ID: 11205457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of central venous catheters in patients with cancer and candidemia.
    Raad I; Hanna H; Boktour M; Girgawy E; Danawi H; Mardani M; Kontoyiannis D; Darouiche R; Hachem R; Bodey GP
    Clin Infect Dis; 2004 Apr; 38(8):1119-27. PubMed ID: 15095217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome.
    Liu CY; Huang LJ; Wang WS; Chen TL; Yen CC; Yang MH; Hsiao LT; Liu CY; Chen PM; Chiou TJ
    J Infect; 2009 Feb; 58(2):154-60. PubMed ID: 19162330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
    Safdar A; Bannister TW; Safdar Z
    Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult candidemia at a medical center in northern Taiwan: a retrospective study.
    Tsai CC; Wang CC; Kuo HY; Chiang DH; Lin ML; Liu CY; Yang SP
    J Microbiol Immunol Infect; 2008 Oct; 41(5):414-21. PubMed ID: 19122924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-species candidemia in patients with cancer.
    Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
    Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable mortality of nosocomial candidemia, revisited.
    Gudlaugsson O; Gillespie S; Lee K; Vande Berg J; Hu J; Messer S; Herwaldt L; Pfaller M; Diekema D
    Clin Infect Dis; 2003 Nov; 37(9):1172-7. PubMed ID: 14557960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Myoken Y; Kyo T; Sugata T; Murayama SY; Mikami Y
    Haematologica; 2006 Feb; 91(2):287-8. PubMed ID: 16461328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of adverse outcome from candidal infection in a tertiary care hospital.
    Ben-Abraham R; Keller N; Teodorovitch N; Barzilai A; Harel R; Barzilay Z; Paret G
    J Infect; 2004 Nov; 49(4):317-23. PubMed ID: 15474630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.